Routes of delivery for progesterone and progestins

Maturitas

Volumn 57, Issue 1, 2007, Pages 77-80

  Sitruk Ware, Regine ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Intrauterine delivery; Metered dose transdermal system; Nestorone; Progesterone; Transdermal progestins; Vaginal progesterone gel and ring

Indexed keywords

ELCOMETRINE; ESTRADIOL; GESTAGEN; LEVONORGESTREL; NORETHISTERONE ACETATE; PROGESTERONE;

ARTICLE; DRUG DELIVERY SYSTEM; HORMONAL THERAPY; HUMAN; POSTMENOPAUSE; UTERUS; VAGINA RING;

ADMINISTRATION, CUTANEOUS; DRUG ADMINISTRATION ROUTES; ESTROGEN REPLACEMENT THERAPY; FEMALE; GELS; HUMANS; INTRAUTERINE DEVICES, MEDICATED; POSTMENOPAUSE; PROGESTERONE; PROGESTINS;

EID: 34247152428     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2007.02.015     Document Type: Article

References (16)

1. Sitruk-Ware R. New progestogens: a review of their effects in perimenopausal and postmenopausal women. Drugs Aging 21 13 (2004) 865-883
2. Sitruk-Ware R. Delivery options for contraceptives. Drug Discov Today 10 14 (2005) 977-985
3. Cicinelli E., and de Ziegler D. Transvaginal progesterone: evidence for a new functional 'portal system' flowing from the vagina to the uterus. Hum Reprod Update 5 4 (1999) 365-372
4. Cicinelli E., de Ziegler D., Bulletti C., Matteo M.G., Schonauer L.M., and Galantino P. Direct transport of progesterone from vagina to uterus. Obstet Gynecol 95 3 (2000) 403-406
5. de Ziegler D., Ferriani R., Moraes L.A., and Bulletti C. Vaginal progesterone in menopause: Crinone 4% in cyclical and constant combined regimens. Hum Reprod 15 Suppl. 1 (2000) 149-158
6. Casanas-Roux F., Nisolle M., Marbaix E., Smets M., Bassil S., and Donnez J. Morphometric, immunohistological and three-dimensional evaluation of the endometrium of menopausal women treated by oestrogen and Crinone, a new slow-release vaginal progesterone. Hum Reprod 11 February (2) (1996) 357-363
7. Zegers-Hochschild F., Balmaceda J.P., Fabres C., et al. Prospective randomized trial to evaluate the efficacy of a vaginal ring releasing progesterone for IVF and oocyte donation. Hum Reprod 15 10 (2000) 2093-2097
8. Alexander N.J., Baker E., Kaptein M., Karck U., Miller L., and Zampaglione E. Why consider vaginal drug administration?. Fertil Steril 82 1 (2004) 1-12
9. Maruo T., Mishell D.R., Ben-Chetrit A., Hochner-Celnikier D., Hamada A.L., and Nash H.A. Vaginal rings delivering progesterone and estradiol may be a new method of hormone replacement therapy. Fertil Steril 78 November (5) (2002) 1010-1016
10. Croxatto H.B., and Zepeda A. Transdermal contraceptive systems: innovative technology for the twenty-first century. In: Sitruk-Ware R., and Bardin W. (Eds). Contraception. Newer Pharmacological Agents, Devices, and Delivery Systems (1992), Marcel Dekker, Inc. 101-115
11. ® clinical applications for contraception and HRT. Steroids 68 (2003) 907-913
12. Rubinacci A., Peruzzi E., Modena A.B., et al. Effect of low-dose transdermal E2/NETA on the reduction of postmenopausal bone loss in women. Menopause 10 May-June (3) (2003) 241-249
13. Sturdee D.W., van de W.P., and von Holst T. Endometrial safety of a transdermal sequential estradiol-levonorgestrel combination. Climacteric 5 2 (2002) 170-177
14. Luukkainen T., Lahteenmaki P., and Toivonen J. Levonorgestrel-releasing intrauterine device. Ann Med 22 2 (1990) 85-90
15. Sitruk-Ware R., and Inki P. The Levonorgestrel intrauterine system: long-term contraception and therapeutic effects. Womens Health 1 2 (2005) 171-182
16. Sturdee D.W., Rantala M.L., Colau J.C., Zahradnik H.P., and Riphagen FE. the acceptability of a small intrauterine progestogen-releasing system for continuous combined hormone therapy in early postmenopausal women. Climacteric 7 4 (2004) 404-411